Myostatin

Definition

Myostatin (also called Growth Differentiation Factor 8, GDF-8) is a member of the TGF-β superfamily that acts as a negative regulator of skeletal muscle growth. Produced primarily by skeletal muscle cells, myostatin signals through activin type II receptors to limit muscle fibre hypertrophy and hyperplasia.

Mechanism of Action

Myostatin signals through ActRIIB (activin receptor type IIB), activating Smad2/3 transcription factors that suppress myogenic gene expression. This pathway inhibits satellite cell activation, reduces protein synthesis via mTOR suppression, and promotes protein degradation through the ubiquitin-proteasome system.

Natural loss-of-function mutations in the myostatin gene produce dramatically increased muscle mass — demonstrated in Belgian Blue cattle, whippet dogs (“bully whippets”), and rare human cases. These observations established myostatin as a validated target for muscle growth research.

Relevance to Peptide Research

Myostatin inhibition is an active area of peptide and biologic research. Follistatin, a natural myostatin antagonist, and follistatin-derived peptides are studied for their ability to block myostatin-ActRIIB signalling. ACE-031 (a soluble ActRIIB decoy receptor) and bimagrumab (an ActRIIB antibody) represent therapeutic approaches targeting the same pathway. Myostatin research intersects with peptides studied for muscle wasting, sarcopenia, and cachexia, including growth hormone secretagogues and IGF-1 analogues that may counteract myostatin’s catabolic signalling.

Related Peptides

Peptide profiles that reference “Myostatin” in their research content.